Literature DB >> 1321855

A kinetic study of immune mediators in the lungs of mice infected with influenza A virus.

T Hennet1, H J Ziltener, K Frei, E Peterhans.   

Abstract

We investigated a broad spectrum of immunoactive mediators in a mouse model of influenza. ICR mice (4-5 wk old) that were infected with a 10 LD50 dose of influenza A/PR8/34 virus died after 6 days without evidence of bacterial superinfection. Maximal virus titers were reached by day 2 postinfection, whereas the multifocal pneumonia with mononuclear cell infiltration reached its maximum at the end of infection. We measured the cytokines IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-6, IFN-gamma, TNF-alpha, granulocyte (G)/macrophage (M)-CSF, G-CSF, M-CSF, and the lipid mediators leukotriene B4 and platelet-activating factor in the cellfree bronchoalveolar lavage fluid of mice during infection. We found an early increase of IL-1 alpha, IL-1 beta, IL-6, TNF-alpha, GM-CSF, IFN-gamma, and leukotriene B4. Levels of these factors peaked between 36 h and day 3 postinfection, with the exception of IL-6 that remained at elevated levels throughout infection. G-CSF and M-CSF increased slowly and reached a maximum by day 5 postinfection. We were unable to detect IL-2, IL-3, or IL-4. PAF remained at the same level throughout infection. Our results suggest that lung-resident cells, and possibly the alveolar macrophages, participate actively in the onset of the inflammatory response against the invading virus. The inability to detect the T cell products IL-2, IL-3, and IL-4 was unexpected considering the role of T cells in the elimination of the virus in infected mice. Our observation confirms thus earlier findings about the inability of specific T cell clones to elicit an unspecific antiviral effect.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321855

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

Review 2.  Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis.

Authors:  Dionne P Robinson; Sabra L Klein
Journal:  Horm Behav       Date:  2012-03-03       Impact factor: 3.587

3.  Differential effects of stimulatory factors on natural killer cell activities of young and aged mice.

Authors:  Shoko Nogusa; Donna M Murasko; Elizabeth M Gardner
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-27       Impact factor: 6.053

4.  Effect of intranasal administration of Lactobacillus casei Shirota on influenza virus infection of upper respiratory tract in mice.

Authors:  T Hori; J Kiyoshima; K Shida; H Yasui
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

Review 5.  Systemic responses during local viral infections: type I IFNs sound the alarm.

Authors:  Carolina B López; Tamar Hermesh
Journal:  Curr Opin Immunol       Date:  2011-07-13       Impact factor: 7.486

6.  Aryl hydrocarbon receptor targets pathways extrinsic to bone marrow cells to enhance neutrophil recruitment during influenza virus infection.

Authors:  Sabine Teske; Andrea A Bohn; Jason P Hogaboam; B Paige Lawrence
Journal:  Toxicol Sci       Date:  2007-11-15       Impact factor: 4.849

7.  Effect of Quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection.

Authors:  Pankaj Kumar; Sonal Sharma; MadhU Khanna; Hanumantharao Guru Raj
Journal:  Int J Exp Pathol       Date:  2003-06       Impact factor: 1.925

8.  Influenza A virus replication is inhibited by tumor necrosis factor-alpha in vitro.

Authors:  H Van Campen
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

Review 9.  H5N1 pathogenesis studies in mammalian models.

Authors:  Jessica A Belser; Terrence M Tumpey
Journal:  Virus Res       Date:  2013-02-28       Impact factor: 3.303

Review 10.  Innate sensors of influenza virus: clues to developing better intranasal vaccines.

Authors:  Takeshi Ichinohe; Akiko Iwasaki; Hideki Hasegawa
Journal:  Expert Rev Vaccines       Date:  2008-11       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.